Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials (Q35747285)
Jump to navigation
Jump to search
scientific article published on 6 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials |
scientific article published on 6 April 2011 |
Statements
1 reference
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials (English)
1 reference
T Reiman
1 reference
R Lai
1 reference
A S Veillard
1 reference
E Paris
1 reference
R Rosell
1 reference
M Taron
1 reference
S Graziano
1 reference
R Kratzke
1 reference
L Seymour
1 reference
F A Shepherd
1 reference
J P Pignon
1 reference
P Sève
1 reference
LACE-Bio Group
1 reference
6 April 2011
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference